Koor, the giant Histadrut company, has announced that its subsidiary, Koor Intertrade-America, which introduces Israeli products to the United States, is expected to earn $100 million this year. Its turnover last year was $84 million. Koor also said that its pharmaceutical company Plantex, has received American approval to export $4.5 million of new drugs to the United States, including medicine for heart treatment, anti-inflammation and Parkinson’s Disease. The company’s total exports to the U.S. is expected to reach $50 million in 1977. Koor Intertrade-Europe has also been selected by the International Telephone and Telegraph Co. to market in Europe electronic devices produced by ITT’s subsidiary.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
